日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Co-targeting SKP2 and KDM5B inhibits prostate cancer progression by abrogating AKT signaling with induction of senescence and apoptosis.

SKP2 和 KDM5B 的共同靶向作用可通过抑制 AKT 信号传导并诱导衰老和凋亡来抑制前列腺癌的进展

Brown LaKendria K, Kanagasabai Thanigaivelan, Li Guoliang, Celada Sherly I, Rumph Jelonia T, Adunyah Samuel E, Stewart LaMonica V, Chen Zhenbang

SHP2 promotes sarcoidosis severity by inhibiting SKP2-targeted ubiquitination of TBET in CD8(+) T cells

SHP2通过抑制CD8(+) T细胞中SKP2靶向的TBET泛素化作用,促进结节病病情加重。

Celada, Sherly I; Lim, Clarice X; Carisey, Alexandre F; Ochsner, Scott A; Arce Deza, Carlos F; Rexie, Praveen; Poli De Frias, Fernando; Cardenas-Castillo, Rafael; Polverino, Francesca; Hengstschläger, Markus; Tsoyi, Konstantin; McKenna, Neil J; Kheradmand, Farrah; Weichhart, Thomas; Rosas, Ivan O; Van Kaer, Luc; Celada, Lindsay J

MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway

MicroRNA-21 缺乏通过下调 IRS1-SREBP-1 信号通路抑制前列腺癌进展

Kanagasabai, Thanigaivelan; Li, Guoliang; Shen, Tian Huai; Gladoun, Nataliya; Castillo-Martin, Mireia; Celada, Sherly I; Xie, Yingqiu; Brown, Lakendria K; Mark, Zaniya A; Ochieng, Josiah; Ballard, Billy R; Cordon-Cardo, Carlos; Adunyah, Samuel E; Jin, Renjie; Matusik, Robert J; Chen, Zhenbang